MedTrace Logo

A Study to Evaluate the Dentinal Hypersensitivity Efficacy of Two Experimental Mouthwash Formulations

NCT07741032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2026-08-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the clinical efficacy of two experimental mouthwash formulations, against a placebo mouthwash (without experimental ingredients). One experimental formulation to be used either once daily or twice daily, and the second experimental formulation and placebo, to be used twice daily for the treatment of dentinal hypersensitivity.

Conditions

  • Dentine Hypersensitivity

Interventions

OTHER

3% KNO3 Mouthwash

3.0% weight by weight (w/w) KNO3 with 217 parts per million (ppm) sodium fluoride.

OTHER

2% HPC Mouthwash

2.0% w/w HPC mouthwash with 217ppm sodium fluoride.

OTHER

0% KNO3 Mouthwash

0% w/w KNO3 with 217ppm sodium fluoride.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-26
Primary Completion
2012-07-09
Completion
2012-07-09

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741032 on ClinicalTrials.gov